MIRA INFORM REPORT

 

 

Report Date :

27.10.2012

 

IDENTIFICATION DETAILS

 

Name :

SM EMPREENDIMENTOS FARMACÊUTICOS LTDA

 

 

Formerly Known As :

FAGRON DO BRASIL FARMACEUTICA LTDA

 

 

Registered Office :

Rua Jurupari, 775 779 E 803 - Jardim Oriental , Zip Code 04348-070 - São Paulo/Sp

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2008

 

 

Date of Incorporation :

25.06.1974

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Wholesaler of chemicals

 

 

No. of Employees :

150 employees

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

Brazil - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. In 2008, Brazil became a net external creditor and two ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Rising inflation led the authorities to take measures to cool the economy; these actions and the deteriorating international economic situation slowed growth to 2.7% for 2011 as a whole, though forecasts for 2012 growth are somewhat higher. Despite slower growth in 2011, Brazil overtook the United Kingdom as the world's seventh largest economy in terms of GDP. Urban unemployment is at the historic low of 4.7% (December 2011), and Brazil's traditionally high level of income equality has declined for each of the last 12 years. Brazil's high interest rates make it an attractive destination for foreign investors. Large capital inflows over the past several years have contributed to the appreciation of the currency, hurting the competitiveness of Brazilian manufacturing and leading the government to intervene in foreign exchanges markets and raise taxes on some foreign capital inflows. President Dilma ROUSSEFF has retained the previous administration's commitment to inflation targeting by the central bank, a floating exchange rate, and fiscal restraint.

 

Source : CIA

 


Company name

 

SM EMPREENDIMENTOS FARMACÊUTICOS LTDA

 

 

company ADDRESSES

 

MAIN ADDRESS:

RUA JURUPARI, 775 779 E 803 - JARDIM ORIENTAL

ZIP CODE/CITY:

04348-070 - SÃO PAULO/SP

 

 

PHONE:

11 5033-3700

FAX:

11 5033-3700

E-MAIL:

alinesilva@fagron.com.br

WEB SITE:

www.fagron.com.br

 

BRANCHES:

 

 

 

ADDRESS:

RUA LABATUT, 403 PARTE - IPIRANGA

ZIP CODE/CITY:

04214-000 SÃO PAULO/SP

 

 

ADDRESS:

AVENIDA DR. HUGO BEOLCHI, 445 14º ANDAR - CONCEIÇÃO

ZIP CODE/CITY:

04310-030 SÃO PAULO/SP

 

 

ADDRESS:

RUA JOSE MARINO FILHO, 200

ZIP CODE/CITY:

04347-180 SÃO PAULO/SP

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

WHOLESALE OF CHEMICALS

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

25/06/1974

REGISTER DATE:

25/06/1974

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

44.015.477/0001-16

STATE REGISTER:

109.235.767.110

 

 

SHARE CAPITAL:

R$ 8.475.000,00

 

BOARD OF DIRECTORS:

 

 

 

RAFAEL PADILLA PAPACEIT

MANAGING PARTNER

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

FAGRON EMPREENDIMENTOS E PARTICIPAÇÕES LTDA

R$ 8.474.943,50

RAFAEL PADILLA PAPACEIT

R$ 56,50

 

AFFILIATES / SUBSIDIARIES:

 

 

 

FAGRON GROUP

 

 

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON JUNE 25, 1974 AS DEG IMPORTAÇÃO DE PRODUTOS QUIMICOS LTDA. TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON JANUARY 26, 2012 IT ALTERED TO FAGRON DO BRASIL FARMACEUTICA LTDA. ON AUGUST 08, 2012 IT ADOPTED THE ABOVE MENTIONED NAME AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN.

 

PARTNERS:

 

RAFAEL PADILLA PAPACEIT: SPANISH, MARRIED, HOLDER OF DOCUMENTS RNE # V729693-X AND CPF # 234.691.188-76, RESIDENTIAL ADDRESS AT RUA REVERENDO MIGUEL RIZZO JUNIOR, 35, CASA 02, MORUMBI, ZIP CODE 05655-100, SÃO PAULO/SP.

 

FAGRON EMPREENDIMENTOS E PARTICIPAÇÕES LTDA: HEADQUARTERED AT RUA JURUPARI, 775/779 E 803, JARDIM ORIENTAL, ZIP CODE 04348-070, SÃO PAULO/SP, TAXPAYER'S REGISTRATION UNDER 12.846.425/0001-03, REGISTERED AT THE STATE OF SÃO PAULO NOTARY OFFICE UNDER # NIRE 35.224.888.284.

 

FURTHER DETAILS ARE SO FAR NOT KNOWN.

 

REMARKS:

--------

 

WHEN INTERVIEWED SOURCES AT THE SUBJECT STATED THAT ARE STILL WAITING FOR AUTHORIZATION FROM THE PRINCIPALS TO PROVIDE THE DATA NECESSARY TO COMPLETE THIS REPORT.

 

A REQUEST FOR FURTHER DATA HAS BEEN SENT TO THE COMPANY. PROVIDED THE DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A COMPLEMENTARY REPORT WILL BE SENT TO YOUR ATTENTION.

 

THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES USUALLY INVESTIGATED.

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

 

FINANCIAL INFORMATION

 

DUE TO THE SUBJECT'S LEGAL FORM, IT IS NOT OBLIGED TO PUBLISH THE BALANCE SHEET INFORMATION. WHEN INTERVIEWING SOURCES AT THE SUBJECT COMPANY DECLINED TO PROVIDE ANY KIND OF FINANCIAL INFORMATION.

 

OUTSIDE SOURCES CONTACTED SHOWED THE FOLLOWING FINANCIAL DATA ABOUT THIS COMPANY. NO MORE UPDATE OR COMPLETE IS AVAILABLE.

 

 

GENERAL BALANCE SHEETS AS OF 31/12/2008.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2008

 

 

 

 

 

 

CASH AND BANKS

143.653,67

 

 

INVENTORY

9.704.288,62

 

 

RECOVERABLE TAXES

205.562,31

 

 

ADVANCES

247.911,29

 

 

ACCOUNTS RECEIVABLE

53.985,85

 

 

CLIENTS

2.270.386,33

 

 

 

----------------

 

 

TOTAL CURRENT ASSETS

12.625.788,07

 

 

 

FIXED ASSETS:

 

 

 

 

 

 

 

FIXED ASSETS

6.810.411,24

 

 

 

----------------

 

 

TOTAL FIXED ASSETS

6.810.411,24

 

 

 

================

 

 

TOTAL ASSETS

19.436.199,31

 

 

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2008

 

 

 

 

 

 

SUPPLIERS

7.993.924,76

 

 

LOANS AND FINANCING

848.896,82

 

 

SALARY, TAXES & CONTRIB.

197.027,80

 

 

TAXES & CONTRIBUTIONS

825.665,72

 

 

PROVISIONS

464.626,52

 

 

ACCOUNTS PAYABLE

111.874,39

 

 

SOCIAL OBLIGATIONS

127.539,89

 

 

 

----------------

 

 

TOTAL CURRENT LIABILITIES

10.569.555,90

 

 

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

392.303,91

 

 

SUPPLIERS

2.238.456,28

 

 

 

----------------

 

 

TOTAL LONG TERM LIABILITIES

2.630.760,19

 

 

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

1.500.000,00

 

 

ACCRUED PROFIT (LOSS)

-277.561,78

 

 

PROFIT (LOSS) OF PERIOD

5.013.445,00

 

 

 

----------------

 

 

TOTAL NET EQUITY

6.235.883,22

 

 

 

================

 

 

TOTAL LIABILITIES

19.436.199,31

 

 

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2008.

( FIGURES ARE IN REAIS ).

 

 

31/12/2008

 

 

 

 

 

 

GROSS SALES

60.433.611,03

 

 

(-) TAXES ON SALES

11.210.728,17

 

 

 

----------------

 

 

NET SALES

49.222.882,86

 

 

(-) COST OF SOLD GOODS

27.579.098,54

 

 

 

----------------

 

 

GROSS PROFIT

21.643.784,32

 

 

OPERATING REVENUE (EXPENSE)

-12.496.793,69

 

 

FINANCIAL REVENUE(EXPENSE)

-1.371.924,32

 

 

 

----------------

 

 

OPERATIONAL PROFIT (LOSS)

7.775.066,31

 

 

NON-OPERATING RESULT

-144.992,78

 

 

CONTRIBUTION/INCOME TAX

-2.616.628,53

 

 

 

----------------

 

 

NET PROFIT (LOSS)

5.013.445,00

 

 

 

MONTHLY SALES

 

  2009

 

 

 

---------------------

 

 

JANUARY

R$ 6.071.445,76

 

 

FEBRUARY

R$ 5.032.786,07

 

 

MARCH

R$ 6.711.965,27

 

 

APRIL

R$ 6.056.653,84

 

 

MAY

R$ 6.188.719,68

 

 

JUNE

 

 

 

JULY

 

 

 

AUGUST

 

 

 

SEPTEMBER

 

 

 

OCTOBER

 

 

 

NOVEMBER

 

 

 

DECEMBER

 

 

 

TOTAL

R$ 30.061.570,62

 

 

 

RATIOS:

31/12/2008

 

 

 

QUICK RATIO

,28

 

 

 

 

 

CURRENT RATIO

1,19

 

 

 

 

 

ACCOUNTS RECEIVABLE TURNOVER

21,68

TIMES

 

 

 

 

DAYS' SALES IN RECEIVABLES

16,60

DAYS

 

 

 

 

INVENTORY TURNOVER

2,84

TIMES

 

 

 

 

ACCOUNTS PAYABLE PERIOD

104,35

DAYS

 

 

 

 

RETURN ON ASSETS

2,53

TIMES

 

 

 

 

SALES TURNOVER ON NET EQUITY

7,89

TIMES

 

 

 

 

NET WORTH TIE-UP

1,09

 

 

 

 

 

INDEBTEDNESS

2,12

 

 

 

 

 

EQUITY RATIO

32,08

%

 

 

 

 

WORKING CAPITAL RATIO

19,45

%

 

 

 

 

GENERAL SOLVENCY

1,47

 

 

 

 

 

RETURN ON NET EQUITY

80,40

%

 

 

 

 

RETURN ON SALES (PROFIT MARGIN)

10,19

%

 

 

 

 

GROSS PROFIT MARGIN

43,97

%

 

 

 

 

OPERATIONAL RESULT

15,80

%

 

 

 

 

SALES TURNOVER ON LIABILITIES

4,66

TIMES

 

 

 

 

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,02

 - OFFICIAL RATE ON 24/10/2012

US$ 1,00 = R$ 2,33

 - OFFICIAL RATE ON 31/12/2008

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS REMAINS HIGH BUT IT HAS NORMAL CURRENT RATIO AND POSITIVE WORKING CAPITAL. IN ADDITION, IT SHOWS HIGH SALES VOLUME AND GOOD PROFITABILITY.

 

REMARK:

 

THE COMPANY DECLINED TO DISCLOSE UPDATED FINANCIAL DATA.

 

REAL ESTATE:

OWNED PREMISES ARE VALUED AT R$ 205.000,00

 

VEHICLES:

OWNED VEHICLES ARE VALUED AT R$ 120.501,65

 

MACHINES:

OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 112.819,42

 

 

INSURANCE

 

INSURANCE COMPANY:

CIA. SEGUROS ALIANÇA DO BRASIL

COVERAGE:

FIRE

 

 

INSURANCE COMPANY:

PORTO SEGURO CIA. DE SEGUROS GERAIS

COVERAGE:

VEHICLES

 

 

INSURANCE COMPANY:

ROYAL & SUN ALIANCE CIA SEGUROS

COVERAGE:

DOMESTIC TRANSPORTATION

EXPIRATION:

UNDETERMINED

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

CITY:

BANCO BRADESCO S/A

3392-8 (11 5069-4300)

SÃO PAULO/SP

BANCO DO BRASIL S/A

3347-2 (11 5054-5454)

SÃO PAULO/SP

BANCO SANTANDER (BRASIL) S/A

1771

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE IMPORT AND WHOLESALE OF CHEMICAL PRODUCTS.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

GERMANY, ARGENTINA, INDIA, KOREA, U.S.A., CHINA, SWITZERLAND, ITALY, JAPAN, HOLLAND AND DENMARK. THE EXACT IMPORT AMOUNT WAS NOT GIVEN BUT SOURCES AT THE COMPANY STATED THAT IMPORTS REPRESENT OVER 50% OF THE TOTAL PURCHASES

 

EXPORTS TO:

PARAGUAY AND MEXICO.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

 

FARMACIA BIOFORMULA IMPORTAÇÃO E EXPORTAÇÃO LTDA

 

 

FARMACIA BUENOS AIRES LTDA

 

 

FARMACIA CIENTIFICA LTDA

SÃO PAULO/SP

 

FARMACIA ESSENCIAL LTDA

 

 

FARMACIA MANIFARMA LTDA

SÃO PAULO/SP

 

FARMACIA MOVIMOTO LTDA

SALVADOR/BA

 

HOPITAL DAS CLINICAS

SÃO PAULO/SP

 

NATURAL PHARMA PROD. FARMACÊUTICOS LTDA

 

 

O FUMULARIO FARMACIA DE MANIPULAÇÃO LTDA

 

 

PHARMACIA ESENCIAL LTDA ME

 

 

QUANTA FARMACIA DE MANIPULAÇÕES LTDA

 

 

 

STAFF:

 

THE COMPANY HAS: 150 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS AN OLD-ESTABLISHED COMPANY OPERATING SINCE 1974 WITH A CLEAR TRADE HISTORY. IT IS FAMILY OWNED AND BOTH THE COMPANY AND THE PRINCIPALS ENJOY A FAVORABLE REPUTATION AMONG LOCAL TRADE SOURCES INVESTIGATED.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

CITY:

PHONE:

AB FARMO QUIMICA LTDA

ANÁPOLIS/GO

62  316-3420

AUROBINDO PHARMA PROD FARMAC LTDA

ANÁPOLIS/GO

11 2161-0821

BASF S/A

SÃO BERNARDO DO CAMPO/SP

11 4343-3341

BERACA SEBARA QUIM INGREDIENTES LTDA

SANTA BARBARA D OESTE/SP

19 3455-8900

CARDINAL HEALTH BRASIL 402 LTDA

SOROCABA/SP

15 3235-3501

CATALENTE BRASIL LTDA

 

15 3235-3501

CHEMSPECS COMÉRCIO REPRESENTAÇÕES LTDA

SÃO PAULO/SP

11 3392-1455

CHEMYUNION QUIMICA LTDA

SOROCABA/SP

11 2173-0103

COLBRAS INDÚSTRIA E COMERCIO LTDA

COTIA/SP

11 3405-5856

DUPONT CIPATEX S/A

CERQUILHO/SP

11 4166-8538

GLOBE QUIMICA LTDA

COSMÓPOLIS/SP

19 3872-8743

INDUKERN DO BRASIL QUIMICA LTDA.

 

 

INDÚSTRIA QUIMICA ANASTACIO S/A

SÃO PAULO/SP

11 2133-6600

IQ SOLUÇÕES & QUIMICAS S/A

SÃO PAULO/SP

11 2195-9067

ISP DO BRASIL LTDA

SÃO PAULO/SP

11 3649-0476

LABORATÓRIOS PFIZER LTDA

RIO DE JANEIRO/RJ

21 2432-5167

LIBBS FARMACÊUTICA LTDA

SÃO PAULO/SP

11 3879-2500

LUBRIZOL DO BRASIL ADITIVOS LTDA

RIO DE JANEIRO/RJ

21 2762-5800

M CASSAB COM E INDUSTRIA LTDA

SÃO PAULO/SP

11 2162-7788

MAPRIC PRODS FARMACOSMÉTICOS LTDA ME

SÃO PAULO/SP

11 5061-5282

MERCK S/A INDS QUIMICAS

COTIA/SP

11 3346-8575

QUIMER COMERCIAL LTDA

SÃO PAULO/SP

11 2955-8800

ROUSSELOT GALETINAS DO BRASIL S/A

AMPARO/SP

19 3907-9003

SANRISIL S/A IMP EXPORTAÇÃO

ITAQUAQUECETUBA/SP

11 2161-0606

SANTOSFLORA COM DE ERVAS LTDA

SÃO PAULO/SP

11 6191-8787

TECNOCART EMBALAGENS LTDA

DIADEMA/SP

11 4056-2566

VALDEQUIMICA PRODUTOS QUIMICOS LTDA

SÃO PAULO/SP

11 3722-3738

 

FOREIGN SUPPLIERS:

COUNTRY:

PHONE:

AARTI DRUGS LIMITED

INDIA

 

BIESTERFELD SIEMSGLUSS INTERN. GMBH

GERMANY

 

CHANGZHOU COMWIN FINE CHEMICAL CO.

CHINA

 

CORNELIUS PHARMACEUTICALS PVT LTD

INDIA

+91-40-23754482

DIVIS PHARMACEUTICALS PVT LTD.

INDIA

 

FERRO IM UND EXPORT GMBH

GERMANY

+ 49- 40- 3068680

G & F HANSE BIOPHARMA GMBH

GERMANY

 

IFFECT CHEMPHAR CO. LTD

CHINA

+86- 755-83741596

IPCA LABORATORIES LIMITED

INDIA

91-22 28686097

IPCA LABORATORIES LIMITED

INDIA

 

LEE PHARMA PVT LTD.

INDIA

 

NINGBO FREE TRADE ZONE PANGS INT`L

CHINA

 

RHENOCHEM AG

SWISS

 

RICERA AMERICAN CORPORAITON

USA

+ 1-727-865-1101

SINOCHEM NINGBO LTD

CHINA

+86- 574-87260165

SUNJI TRADING COMPANY

CHINA

+86- 755-25566479

TIANJIN TIANMAO TECHNOLOGY DEVELOPMENT CORP. LTD

CHINA

+86-22-23709100

TRICON ENTERPRISES PVT. LTD.

INDIA

 

WHITE INTERNATIONAL LIMITED

UNITE KINGDOM

 

XI`AN HIGH-TECH INDUSTRIES CO. LTD.

CHINA

 

 

PAYMENT HISTORY:

 

05 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 111.049,00

 

AMOUNT OF INVOICES PAID: 40

TOTAL OF PROMPT PAYMENTS: 72,4%

TOTAL OF DELAYED PAYMENTS: 27,6%

 

HIGHEST INVOICE: R$ 28.096,00

HIGHEST CREDIT: R$ 28.096,00

 

 

 

 

FINAL OPINION

 

THE CONCERN IS AN OLD-ESTABLISHED COMPANY, IN BUSINESS SINCE 1974. SO FAR NO COMPLAINT HAS BEEN HEARD AGAINST IT, WHAT SHOWS SUBJECT FULFILLS ITS TRADE COMMITMENTS PROPERLY.

 

BASED ON THE OVERALL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S SIZE AND FINANCIAL STRENGTH.

 

 

 


 

SM EMPREENDIMENTOS FARMACÊUTICOS LTDA

 

 

BALANCE SHEET ANALYSIS

FIGURES ARE IN REAIS

 

 

31/12/2008

 

ASSETS

 

%

Current Assets

 $            12,625,788

64.96

Fixed Assets

 $              6,810,411

35.04

TOTAL ASSETS

 $            19,436,199

100.00

LIABILITIES

 

 

Current Liabilities

 $            10,569,556

54.38

Long-Term Liabilities

 $              2,630,760

13.54

TOTAL LIABILITIES

 $            13,200,316

67.92

Deferred Income

 $                            -  

0.00

Net Equity

 $              6,235,883

32.08

TOTAL LIABILITIES + NET EQUITY

 $            19,436,199

100.00

PROFIT AND LOSS ACCOUNTS

 

 

Net Sales

 $            49,222,883

100.00

Costs

 $            27,579,099

56.03

Gross Profit

 $            21,643,784

43.97

Operating expenses

 $          (12,496,794)

-25.39

operational Result

 $              7,775,066

15.80

Net Profit (loss)

 $              5,013,445

10.19

COMPLEMENTARY DATA

 

 

Inventory

 $              9,704,289

 

Accounts receivable

 $              2,270,386

 

Accounts Payable

 $              7,993,925

 

Property, plant and equipment

 $              6,810,411

 

Purchases

 $              6,810,411

 

Financial Expenses

 $             (1,371,924)

 

Foreign Currency Assets

 

 

Foreign Currency Liabilities

 

 

Working Capital

 $              2,056,232

 

RATIOS:

 

 

QUICK RATIO

                           0.28

 

CURRENT RATIO

                           1.19

 

ACCOUNTS RECEIVABLE TURNOVER

                         21.68

times

DAYS' SALES IN RECEIVABLES

                         16.60

days

INVENTORY TURNOVER

                           2.84

times

ACCOUNTS PAYABLE PERIOD

                       104.35

days

RETURN ON ASSETS

                           2.53

times

SALES TURNOVER ON NET EQUIY

                           7.89

times

NET WORTH TIE-UP

                           1.09

 

ENDEBTEDNESS

                           2.12

 

EQUITY RATIO

                         32.08

%

WORKING CAPITAL RATIO

                         19.45

%

GENERAL SOLVENCY

                           1.47

 

RETURN ON NET EQUITY

                         80.40

%

RETURN ON SALES (PROFIT MARGIN)

                         10.19

%

GROSS PROFIT MARGIN

                         43.97

%

OPERATIONAL RESULT

                         15.80

%

SALES TURNOVER ON LIABILITIES

                           4.66

times

FOREIGN CURRENCY ON ASSETS

                               -  

%

FOREIGN CURRENCY ON LIABILITIES

                               -  

%

 

 

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.63

UK Pound

1

Rs.86.18

Euro

1

Rs.69.75

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.